Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
REGN
REGN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
REGN News
FDA Accelerates Biosimilar Drug Development and Approves New Treatments
10h ago
NASDAQ.COM
AstraZeneca's Lung Disease Drug Meets Trial Targets
3d ago
CNBC
Regeneron Faces Challenges but Shows Potential for Recovery
3d ago
Fool
Regeneron's Five-Year Outlook Amid Recovery
3d ago
NASDAQ.COM
Dupixent Approved in Japan for Bullous Pemphigoid Treatment
6d ago
NASDAQ.COM
Dupixent Approved in Japan for Bullous Pemphigoid Treatment
6d ago
Yahoo Finance
Dupixent Approved in Japan for Bullous Pemphigoid Treatment
6d ago
Yahoo Finance
Sanofi and Regeneron's Dupixent Receives Approval in Japan as the First Targeted Treatment for Adults with Bullous Pemphigoid
6d ago
moomoo
Analysis of IBB ETF Trading Dynamics
Mar 20 2026
NASDAQ.COM
CNBC Launches Advocacy Platform for Rare Diseases
Mar 20 2026
CNBC
Formycon Settles with Regeneron, Secures Biosimilar Launch
Mar 19 2026
NASDAQ.COM
Eli Lilly's Dominance in Weight Loss Market
Mar 13 2026
Fool
Eli Lilly's Leadership in Weight Loss Market
Mar 13 2026
NASDAQ.COM
Regeneron's Pipeline Performance Positions Shares for Growth
Mar 12 2026
NASDAQ.COM
Regeneron: Potential for Doubling Returns Ahead
Mar 12 2026
Fool
Regeneron's Obesity Drug Trial Shows Positive Results
Mar 09 2026
NASDAQ.COM
Show More News
